Robichaud, A.J. et al, Ann. Rep. Med. Chem., 35, 2000, pp. 11-20.* |
“Developments in the Treatment of Parkinson's Disease”, Drug and Ther. Bull., 35, 1997, 36-40, no author listed.* |
Draetta, G. and Pagano, M. in “Annual Reports in Medicinal Chemistry, vol. 31”, 1996, Academic Press, San Diego, p241-246.* |
G. Maura et al., “Serotonin 5-HT1D and 5-HT1A Receptors Respectively Mediate Inhibition of Glutamate Release and Inhibition of Cyclic GMP Production in Rat Cerebellum In Vitro,” J. Neurochemistry, 66(1), 203-209 (1996). |
R. Glennon, “Serotonin Receptors: Clinical Implications,” Neuroscience & Biobehav. Rev. 14, 35-47 (1990). |
A. Damasio, “450 Alzheimer's Disease and Related Dementias,” in Cecil Textbook of Medicine, 18th ed., pp. 2075-2079 (W.B. Saunders, Philadelphia 1992). |
A. Goldstein, Addiction: from Biology to Drug Policy, pp. 3-5 (W. Freeman & Co. 1994). |